Status:
TERMINATED
Association of PICP Serum Marker in Patients With LVSD
Lead Sponsor:
Texas Tech University Health Sciences Center
Conditions:
Systolic Dysfunction
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is to determine if the carboxy-terminal of procollagen type I (PICP) can be a useful marker of different degrees of myocardial fibrosis.
Detailed Description
Abnormality of diastolic function, particularly a more advanced form known as restrictive tilling pattern, has been correlated with worse outcome in patients with systolic dysfunction associated with ...
Eligibility Criteria
Inclusion
- Evidence of left ventricular systolic dysfunction (measured LVEF% less than 35%) measured by echocardiography within the previous three months at the time of enrollment
- Greater than or equal to 18 years of age
- Greater than or equal to 110 pounds in weight
Exclusion
- Non-sinus rhythm at the time of enrollment
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00232388
Start Date
September 1 2005
End Date
September 1 2007
Last Update
October 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TTUHSC
Lubbock, Texas, United States, 79430